Genzyme Corporation v. Seikagaku Corporation et al

Patent infringement. The plaintiff is a global biotechnology company with products and services focused on rare inherited disorders, kidney disease, orthopedics, cancer, transplant and immune disease. The defendants have infringed on the plaintiff’s treatment regimen for pain in osteoarthritis with their viscosupplement solution gel, Gel-One. Plaintiff seeks to enjoin the defendants from selling Gel-One.